Dignitana AB (publ) appoints Nomination Committee for Annual General Meeting 2025

The Dignitana Annual General Meeting 2025 will be held on 22 May 2025. The Nomination Committee for the Dignitana Annual General Meeting 2025 consists of:

• Greg Dingizian, Chairman of the Board and Owner of Agartha AB on closely related company's mandate  
• Magnus Sjöqvist, Swedbank Robur Fonder AB on closely related company mandate
• Bill Cronin, UBS Financial Services Inc. on closely related company mandate
• Klas Arildsson, Chairman of the Board

The Nomination Committee shall give proposals for Chairman at the AGM, election, and remuneration of board members and, where applicable, remuneration for work in the board's committees, election and remuneration of auditors and, where applicable, changes of principles for appointment of nomination committee.

Shareholders wishing to make suggestions to the nomination committee may write to investorrelations@dignitana.com by 1 April 2025 at the latest.
 

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com. 

For More Information Contact 

Fredrik Jonsson, CEO, fredrik.jonsson@dignitana.com  +46 708766444